Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Patho-biotechnology: using bad bugs to do good things.

Roy D Sleator1, Colin Hill

  • 1Department of Microbiology & Alimentary Pharmabiotic Centre, University College, Cork, Ireland.

Current Opinion in Biotechnology
|February 7, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Discovery and synthesis of leaderless bacteriocins from the Actinomycetota.

Journal of bacteriology·2024
Same author

You have the microbiome you deserve.

Gut microbiome (Cambridge, England)·2024
Same author

Screening canine sources for novel antimicrobials reveals the circular broad-spectrum bacteriocin, caledonicin, produced by <i>Staphylococcus caledonicus</i>.

Frontiers in microbiology·2024
Same author

Raffinocyclicin is a novel plasmid-encoded circular bacteriocin produced by <i>Lactococcus raffinolactis</i> with broad-spectrum activity against many gram-positive food pathogens.

Applied and environmental microbiology·2024
Same author

Somatic cell count as an indicator of subclinical mastitis and increased inflammatory response in asymptomatic lactating women.

Microbiology spectrum·2024
Same author

LPA3 agonist-producing Bacillus velezensis ADS024 is efficacious in multiple neuroinflammatory disease models.

Brain, behavior, and immunity·2024
Same journal

Microbial C1 assimilation pathways for chemical synthesis: from native metabolism to synthetic design.

Current opinion in biotechnology·2026
Same journal

Medicinal plants fermentation: current knowledge and perspectives.

Current opinion in biotechnology·2026
Same journal

Fermented foods: lessons learned from metagenomics.

Current opinion in biotechnology·2026
Same journal

Microfluidic platforms for the transient transfection of mammalian cells: recent developments and challenges.

Current opinion in biotechnology·2026
Same journal

Harvesting insights from recent advances in yeast genomics for predictable and precision wine fermentation.

Current opinion in biotechnology·2026
Same journal

Minimal enzyme cascades for the aromatic-to-aromatic upgrading of lignin monomers.

Current opinion in biotechnology·2026
See all related articles

Pathogenic bacteria offer novel biotechnological applications, termed patho-biotechnology. Listeria monocytogenes serves as a model organism for developing advanced probiotics and delivery systems.

Area of Science:

  • Microbiology
  • Biotechnology
  • Immunology

Background:

  • Pathogenic bacteria possess sophisticated mechanisms to evade host defenses and modulate immune responses.
  • These bacterial traits can be harnessed for beneficial applications in various fields.

Purpose of the Study:

  • To introduce and define the concept of 'patho-biotechnology'.
  • To highlight the potential of utilizing pathogenic bacterial traits for biotechnological advancements.
  • To establish Listeria monocytogenes as a model organism for this field.

Main Methods:

  • Conceptual framework development for patho-biotechnology.
  • Literature review on bacterial virulence factors and immune interactions.
  • Evaluation of Listeria monocytogenes as a model organism based on its characteristics.

Related Experiment Videos

Main Results:

  • Patho-biotechnology offers a novel approach for developing advanced medical and biotechnological tools.
  • Listeria monocytogenes exhibits key characteristics, including genetic tractability and immune response induction, making it suitable for patho-biotechnology.
  • Potential applications include novel vaccine and drug delivery systems and enhanced probiotic cultures.

Conclusions:

  • Patho-biotechnology represents a promising interdisciplinary field.
  • Listeria monocytogenes is an ideal model for exploring and advancing patho-biotechnology applications.
  • This approach has the potential to yield significant improvements in medicine, biotechnology, and food science.